Kraig Biocraft Laboratories, Inc. KBLB
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 639.10K | 758.80K | 653.90K | 1.42M | 573.90K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 703.40K | 825.50K | 722.70K | 1.43M | 637.70K |
| Operating Income | -703.40K | -825.50K | -722.70K | -1.43M | -637.70K |
| Income Before Tax | -909.50K | -942.70K | -787.60K | -1.51M | -726.10K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -909.50K | -942.70K | -787.60K | -1.51M | -726.10K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -909.50K | -942.70K | -787.60K | -1.51M | -726.10K |
| EBIT | -703.40K | -825.50K | -722.70K | -1.43M | -637.70K |
| EBITDA | -696.30K | -819.30K | -715.10K | -1.43M | -631.90K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 1.11B | 1.09B | 1.08B | 1.07B | 1.05B |
| Average Diluted Shares Outstanding | 1.11B | 1.09B | 1.08B | 1.07B | 1.05B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |